Phase 2 study of intermittent pulse dacomitinib in patients with advanced non-small cell lung cancers.

Yu, Helena A

Phase 2 study of intermittent pulse dacomitinib in patients with advanced non-small cell lung cancers. [electronic resource] - Lung cancer (Amsterdam, Netherlands) 10 2017 - 195-199 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study

1872-8332

10.1016/j.lungcan.2017.08.017 doi


Adult
Aged
Aged, 80 and over
Antineoplastic Agents--administration & dosage
Carcinoma, Non-Small-Cell Lung--drug therapy
Female
Humans
Lung Neoplasms--drug therapy
Male
Middle Aged
Protein Kinase Inhibitors--administration & dosage
Pulse Therapy, Drug
Quinazolinones--administration & dosage